EconPapers    
Economics at your fingertips  
 

What’s Good and Bad About Contraceptive Products?

Stephanie A. Knox (), Rosalie Viney (), Deborah J. Street, Marion R. Haas, Denzil Fiebig, Edith Weisberg and Deborah Bateson
Additional contact information
Stephanie A. Knox: University of Technology Sydney
Deborah J. Street: University of Technology Sydney
Marion R. Haas: University of Technology Sydney
Edith Weisberg: Sydney Centre for Reproductive Health Research
Deborah Bateson: Sydney Centre for Reproductive Health Research

PharmacoEconomics, 2012, vol. 30, issue 12, No 8, 1187-1202

Abstract: Abstract Background In the past decade, the range of contraceptives available has increased dramatically. There are limited data on the factors that determine women’s choices on contraceptive alternatives or what factors providers consider most important when recommending contraceptive products to women. Objectives Our objectives were to compare women’s (consumers’) preferences and GPs’ (providers’) views in relation to existing and new contraceptive methods, and particularly to examine what factors increase the acceptability of different contraceptive products. Methods A best-worst attribute stated-choice experiment was completed online. Participants (Australian women of reproductive age and Australian GPs) completed questions on 16 contraceptive profiles. 200 women of reproductive age were recruited through a commercial panel. GPs from all states of Australia were randomly sampled and approached by phone; 162 GPs agreed to participate. Participants chose the best and worst attribute levels of hypothetical but realistic prescribed contraceptive products. Best and worst choices were modelled using multinomial logit and product features were ranked from best to worst according to the size of model coefficients. Results The most attractive feature of the contraceptive products for both GPs and women consumers were an administration frequency of longer than 1 year and light or no bleeding. Women indicated that the hormonal vaginal ring was the least attractive mode of administration. Conclusions Women and GPs agree that longer-acting methods with less bleeding are important features in preferred methods of contraception; however, women are also attracted to products involving less invasive modes of administration. While the vaginal ring may fill the niche in Australia for a relatively non-invasive, moderately long-acting and effective contraceptive, the results of this study indicate that GPs will need to promote the benefits of the vaginal ring to overcome negative perceptions about this method among women who may benefit from using it.

Keywords: Product Type; Choice Task; Attribute Level; Fractional Factorial Design; Product Profile (search for similar items in EconPapers)
Date: 2012
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.2165/11598040-000000000-00000 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
Journal Article: What’s Good and Bad About Contraceptive Products? (2012) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:30:y:2012:i:12:d:10.2165_11598040-000000000-00000

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.2165/11598040-000000000-00000

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-04-07
Handle: RePEc:spr:pharme:v:30:y:2012:i:12:d:10.2165_11598040-000000000-00000